ADRs Close Lower; Chemomab Therapeutics Ltd. Declines 24%

Dow Jones
Sep 29

This article was automatically generated by Dow Jones using technology from Automated Insights.

International stocks trading in New York closed lower on Monday, as the S&P/BNY Mellon index of American depositary receipts fell 0.1% to 274.97.

The European index was flat at 240.44. The Asian index was flat at 373.01. The Latin American index fell 1.0% to 269.38, while the emerging-markets index declined 0.1% to 618.18.

Chemomab Therapeutics Ltd., based in Israel, posted the largest decline, cratering 24% to $1.64, followed by shares of Switzerland's Addex Therapeutics Ltd., which plummeted 23% to $2.81. Shares of Hong Kong-based Lion Group Holding Ltd. cratered 21% to $5.78.

China's Jinxin Technology Holding Co. was the biggest leader during the session, rocketing 41% to $2.24, and China-based BingEx Ltd. surged 19% to $1.39. Viomi Technology Co. Ltd., which is based in China, rounded out the top three leaders on Monday, with shares jumping 18% to $1.59.

Data source: Dow Jones Market Data, FactSet

 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10